• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample:

    India Radioligand Therapy Market

    India Radioligand Therapy RLT Market Research Report By Isotope (Fluorine – 18, Gallium – 68, Lutetium – 177, Others), By Targeted Receptor (Prostate-specific Membrane Antigen (PSMA), Somatostatin Receptor (SSTR), Epidermal Growth Factor Receptor (EGFR), Others), By Indication (Prostate Cancer, Neuroendocrine Tumors (NETs), Breast Cancer, Others) and By End User (Hospitals & Clinics, Diagnostic Centers, Others) - Forecast to 2035
    India Radioligand Therapy (RLT) Market Research Report - Forecast to 2035 Infographic

    No. of Pages: 150

    Report Code: MRFR/Pharma/50337-HCR

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Contact Us

    Call Us or Write Us

    Write An Email

    [email protected]

    Call Us

    +1 (855) 661-4441(US) / +44 1720 412 167(UK)

    Trusted by 1000+ clients per year